Difference between revisions of "Contexts"
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
=FDA indication language= | =FDA indication language= | ||
| + | ==Early stage== | ||
==Locally advanced== | ==Locally advanced== | ||
| + | ==Advanced== | ||
==Metastatic== | ==Metastatic== | ||
==Relapsed or refractory== | ==Relapsed or refractory== | ||
Revision as of 02:18, 30 November 2020
The purpose of this page is to define treatment contexts used in the HemOnc ontology; it is not for other purposes at this time.